The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater
about
Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activationThe cerebellum and migraineUnderstanding migraine: Potential role of neurogenic inflammationOn serotonin and migraine: a clinical and pharmacological reviewNeurogenic model of migraineNeuropeptides in migraine and cluster headacheCP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meningesTonabersat (SB-220453) a novel benzopyran with anticonvulsant properties attenuates trigeminal nerve-induced neurovascular reflexesAgonistic properties of alniditan, sumatriptan and dihydroergotamine on human 5-HT1B and 5-HT1D receptors expressed in various mammalian cell linesSensitization of the trigeminovascular pathway: perspective and implications to migraine pathophysiology.Triptans reduce the inflammatory response in bacterial meningitis.Migraine pathogenesis and state of pharmacological treatment optionsA fresh look at migraine therapy. New treatments promise improved management.Responses of dural mast cells in concussive and blast models of mild traumatic brain injury in mice: Potential implications for post-traumatic headache.Possible antimigraine mechanisms of action of the 5HT1F receptor agonist LY334370.Nerve fibers innervating the cranial and spinal meninges: morphology of nerve fiber terminals and their structural integration.Neurogenic inflammation in the context of migraine.The trigeminovascular system in bacterial meningitis.Buspirone, but not sumatriptan, induces miosis in humans: relevance for a serotoninergic pupil control.Migraine and function of the immune system: a meta-analysis of clinical literature published between 1966 and 1999.Migraine pathophysiology and its clinical implications.The discovery of a new drug class for the acute treatment of migraine.Blockade by oral or parenteral RPR 100893 (a non-peptide NK1 receptor antagonist) of neurogenic plasma protein extravasation within guinea-pig dura mater and conjunctiva.Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms.Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study.Pearls and pitfalls in experimental in vivo models of migraine: dural trigeminovascular nociception.5-HT(1D) receptor immunoreactivity in the sphenopalatine ganglion: implications for the efficacy of triptans in the treatment of autonomic signs associated with cluster headache.Selective 5-HT1D alpha serotonin receptor gene expression in trigeminal ganglia: implications for antimigraine drug development.Sumatriptan: a selective 5-hydroxytryptamine receptor agonist for the acute treatment of migraine.From serotonin receptor classification to the antimigraine drug sumatriptan.Lack of effect of the antimigraine drugs, sumatriptan, ergotamine and dihydroergotamine on arteriovenous anastomotic shunting in the dura mater of the pig.Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater.Peripheral GABAA receptor-mediated effects of sodium valproate on dural plasma protein extravasation to substance P and trigeminal stimulationIdentification of a prostanoid FP receptor population producing endothelium-dependent vasorelaxation in the rabbit jugular vein.GABAA-receptor-mediated effects of progesterone, its ring-A-reduced metabolites and synthetic neuroactive steroids on neurogenic oedema in the rat meninges.Inhibition of excitatory non-adrenergic non-cholinergic bronchoconstriction in guinea-pig airways in vitro by activation of an atypical 5-HT receptorMast cell degranulation activates a pain pathway underlying migraine headache.Patient outcome in migraine prophylaxis: the role of psychopharmacological agentsNaratriptan: a review.Sumatriptan does not change calcitonin gene-related peptide in the cephalic and extracephalic circulation in healthy volunteers
P2860
Q24564969-C37C5FBA-FCC3-43E1-9912-5C802C0C3FEDQ24628942-0B9B6A94-7EAB-4A40-B4CD-44C380DC9E59Q26747000-E0667AC9-D091-4716-922E-543DB9E4F763Q28263827-84D4B7BA-CEB8-4B5C-AE31-457980B78B49Q28291139-FB42EA9A-47EF-49D6-90C8-66EC97FEDCD9Q28305727-A474AB2E-66A9-4168-9890-D6F3255A1375Q28326822-6A39C873-284A-44E7-A33F-F49D03269054Q28361230-1BB59DAD-A7F4-443B-8907-AFFA1BED140AQ28379537-30999416-C520-4B4E-BE25-2B0A9B852ED3Q30465785-B00F9572-8FEA-480F-A171-DC3C67A08E2AQ30842137-8827B352-9E99-44ED-9BC3-3505E0547D53Q30886663-E4999D54-F188-430F-A181-DFE632CC9A19Q31992250-E03FC7D5-C0E3-40A4-B9D9-8DBA86C72C97Q33882320-C351A110-7E0A-48D6-88F9-97FAE9951A98Q33889433-6FF5036A-0921-49E8-8582-4AED744404D4Q34218274-2ECC06E3-60A6-4660-80D4-0645F7AD616CQ34218309-9E051717-8BE4-4AEA-BC55-DF12D599BCA3Q34218327-E77C729E-CDF7-4A0A-8D68-40F46121DD89Q34307161-686B9000-F9C5-4E23-9CBE-9194B7BF1A63Q34319363-D0E67C94-FF55-4FA3-A999-C1D89070EA30Q34375872-10CFB041-EF8A-4986-9B6E-D922F16FAE53Q34617817-CB612F54-607D-4959-91CC-2E1DBEA8077AQ34662470-CB561A3F-CF4E-47F8-90C7-1CBA14B7B33DQ34662700-BB6FF363-560B-416F-9592-77CBD02F3793Q34663298-F9E972EB-41C0-46DD-994B-E97C82EE8394Q34720188-5CCCB230-1041-463A-9844-146004A56722Q34775138-7CE27586-3FD6-42E2-8482-2C08BBE81075Q35189866-C1A645DA-C43D-4ACC-9325-ED26476ACC73Q35229339-02DF2E1B-67C7-43C2-9234-ECDA6A5F25E4Q35233143-44A2CB75-1482-4E3D-9DCC-8F635339071BQ35871242-330DCD56-1100-4509-9181-2A55E1A9B174Q35872010-983D2DF8-DBCD-461D-8617-A6C1025F33C7Q35872756-D408AEAB-1CB8-4564-95B9-FB6944DDC582Q35873157-CFCF1087-75EE-454F-82B4-2A7A1700CB4DQ35873339-A7998EEB-9A88-4563-9E8C-1E6E9AA07445Q35874503-F087DBCF-094E-4FE9-9E2F-F3DE73BF598DQ36098310-6015D53C-9483-494C-BB4F-EA67E675A0C9Q36160565-745F1A9F-B839-4728-BAFF-21CA344F6BC4Q36181337-F31AAB28-B540-4D4A-B749-20B48A59AA3FQ36259595-C1CC8AAB-4D7B-4BA9-A572-E87D01FE121E
P2860
The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
The antimigraine drug, sumatri ...... om blood vessels in dura mater
@ast
The antimigraine drug, sumatri ...... om blood vessels in dura mater
@en
type
label
The antimigraine drug, sumatri ...... om blood vessels in dura mater
@ast
The antimigraine drug, sumatri ...... om blood vessels in dura mater
@en
prefLabel
The antimigraine drug, sumatri ...... om blood vessels in dura mater
@ast
The antimigraine drug, sumatri ...... om blood vessels in dura mater
@en
P2860
P1476
The antimigraine drug, sumatri ...... om blood vessels in dura mater
@en
P2093
M A Moskowitz
P2860
P304
P356
10.1111/J.1476-5381.1990.TB14679.X
P407
P577
1990-01-01T00:00:00Z